Losartan Potassium
Recommended CardiovascularUnrestrictedFirst-line line
Treatment of hypertension, alone or in combination with other antihypertensives. Also registered for treatment of hypertensive type 2 diabetics with proteinuria to delay progression of renal disease.
1
Submissions
1 resub
2010–10
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Jul 2010Recommended
vs irbesartan
- PBS listing · Unrestricted
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated by design.
The PBAC accepted the sponsor's pre-Sub Committee response offer of a weighted price to account for patients who require a dose of 100 mg in the absence of a 100 mg strength tablet. PBAC · 2010
Decision context
PopulationAdults with essential hypertension and adults with hypertensive type 2 diabetes with proteinuria.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2010 | Recommended | irbesartan | — | RCT |